Clinical Trial Update: T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for T138067 in patients with locally advanced or metastatic non-small cell lung cancer that has not responded to prior chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• T138067

Snippet

Sponsor: Tularik | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN